Abstract.
Unlike most other mammalian cells, β-cells of Langerhans constitutively express cyclooxygenase (COX)-2 rather than COX-1. COX-2 is also constitutively expressed in type 1 diabetes (T1D) patients' periphery blood monocytes and macrophage. To understand the role of COX-2 in the β-cell, we investigated COX-2 expression in β-cells and islet infiltrates of NOD and BALB/c mice using fluorescence immunohistochemistry and cytochemical confocal microscopy and Western blotting. Immunostaining showed that COX-2 is expressed in islet-infiltrating macrophages, and that the expression of insulin and COX-2 disappeared concomitantly from the β-cells when NOD mice progressed toward overt diabetes. Also cultured INS-1E cells coexpressed insulin and COX-2 but clearly in different subcellular compartments. Treatment with celecoxib increased insulin release from these cells in a dose-dependent manner in glucose concentrations ranging from 5 to 17 mM. Excessive COX-2 expression by the islet-infiltrating macrophages may contribute to the β-cell death during insulitis. The effects of celecoxib on INS-1E cells suggest that PGE2 and other downstream products of COX-2 may contribute to the regulation of insulin release from the β-cells.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Luo, C., Kallajoki, M., Gross, R. et al. Cellular distribution and contribution of cyclooxygenase (COX)-2 to diabetogenesis in NOD mouse. Cell Tissue Res 310, 169–175 (2002). https://doi.org/10.1007/s00441-002-0628-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00441-002-0628-6